Effects of Resveratrol and Other Polyphenols on the Most Common Brain Age-Related Diseases

Fiorella Sarubbo1, David Moranta1, Victor J Asensio2

  • 1Departamento de Biologia, Laboratorio de Neurofisiologia, Instituto Universitario de Investigacion en Ciencias de la Salud, Universidad de las Islas Baleares (UIB), Mallorca, Spain.

Abstract

Insights

Polyphenols, natural antioxidant and anti-inflammatory compounds, show promise in preventing brain aging and neurodegenerative diseases like Alzheimer's and Parkinson's. Their consumption may offer neuroprotection and support healthy brain aging.

Area of Science:

  • Neuroscience
  • Gerontology
  • Nutritional Science

Background:

  • Global aging populations necessitate strategies to mitigate age-related neurodegeneration.
  • Oxidative stress and inflammation are key drivers of brain aging.
  • Antioxidant and anti-inflammatory compounds, like polyphenols, are beneficial for brain health.

Purpose of the Study:

  • To review the latest research on polyphenols' positive effects on brain health during aging.
  • To emphasize polyphenol impacts on common age-related brain diseases: Parkinson's (PD), Alzheimer's (AD), dementia, and depression.
  • To explore epigenetic mechanisms mediating polyphenol neuroprotection.

Main Methods:

  • Literature review of studies on dietary polyphenols and brain aging.
  • Analysis of polyphenol mechanisms including antioxidant, anti-inflammatory, and epigenetic effects.
  • Focus on neuroprotection against neurodegenerative diseases.

Main Results:

  • Long-term dietary polyphenol consumption may protect against neurodegenerative diseases.
  • Polyphenols exhibit antioxidant, anti-inflammatory, and modulatory effects on disease-related pathways (epigenetics, amyloid, etc.).
  • Polyphenols offer potential for novel neuroprotective strategies.

Conclusions:

  • Polyphenols positively influence brain health in aging and common age-related diseases.
  • Epigenetic modulation is a key mechanism for polyphenol neuroprotection.
  • Further research into polyphenols presents future challenges and opportunities for brain health.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
278
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
894
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
761
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
267
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K